Food and Drug Administration | CHOP Research Institute
 

Food and Drug Administration

1 - 4 of 4

FDA Approval, Mitochondrial Dysfunction, Pediatric Headaches

Published on
Aug 18, 2023
in Cornerstone Blog
In the News: FDA Approval, Mitochondrial Dysfunction
The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.

Weight and CHD, Tumor Biology, I-ACT Grant, Mitochondrial Disease Guidelines

Published on
Nov 3, 2017
in Cornerstone Blog
CHOP Research In the News
From new insights into brain tumor biology to building a network for pediatric trials, don't miss this week's research roundup.

CAR-T Cell Approval, Hope on Wheels, Task Force on Pregnant Women, Taking Flight for Autism, NFL Concussion Research, Doug Wallace

Published on
Sep 8, 2017
in Cornerstone Blog
CHOP Research In the News
September marks National Childhood Cancer Awareness Month, and this year at Children's Hospital of Philadelphia, we kick-started the commemorative period on the heels of exciting news about breakthroughs in pediatric cancer immunotherapy research.

CTL019 Wins FDA Panel Support, Driving with ADHD, High School Football, New Genetic Syndrome, Teen Bone Growth, Missed Nursing Care

Published on
Jul 13, 2017
in Cornerstone Blog
CHOP Research In the News
CAR T-cell therapy tops this week's research roundup, with news about the experimental immunotherapy designed to re-engineer a patient's cells to fight cancer making late-breaking and captivating headlines across the nation.
1 - 4 of 4